In consistent with this report, we detected a marked reduction of acetylated-SOD2 levels in CLL cells indicating its constitutive enzymatic activity and that, the class-III histone deacetylase SIRT3 remained overexpressed, although at variable levels. This evidence concerns the gene SOD2 and B-cell chronic lymphocytic leukemia.